Skipping this phase or rushing through it is the single most common reason people quit semaglutide in the first month
Analyses of 17 placebo-controlled trials (modal duration of 10 weeks), largely in patients taking atypical antipsychotic drugs, revealed a risk of death in drug-treated patients of between 1.6 to 1.7 times the risk of death in placebo-treated patients
Anecdotal reports from the peptide community are more positive than the clinical data suggests, with some users claiming noticeable reductions in stubborn body fat, particularly in the abdominal area
Mounjaro's appetite suppression and reduced food intake may increase risk of nutritional deficiencies over time, making B12 monitoring important
If nausea is your primary concern, the timing strategy is clear
use within 30 days Timing and Cycling Timing : Morning, fasted for lipolysis synergy